Loading...
XJPX6849
Market cap2.16bUSD
Jan 10, Last price  
2,042.50JPY
1D
-0.99%
1Q
-3.02%
Jan 2017
-21.05%
Name

Nihon Kohden Corp

Chart & Performance

D1W1MN
XJPX:6849 chart
P/E
19.99
P/S
1.53
EPS
102.18
Div Yield, %
1.75%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
4.42%
Revenues
221.99b
+7.45%
83,807,000,00090,367,000,00096,679,000,000104,825,000,000109,123,000,000107,013,000,000113,380,000,000120,718,000,000132,538,000,000153,194,000,000160,803,000,000165,522,000,000166,285,000,000174,249,000,000178,799,000,000185,007,000,000199,727,000,000205,129,000,000206,603,000,000221,986,000,000
Net income
17.03b
-0.49%
6,562,000,0005,788,000,0005,052,000,0005,631,000,0004,610,000,0005,917,000,0006,573,000,0007,621,000,0009,151,000,00012,346,000,00011,142,000,00010,516,000,0009,149,000,0009,154,000,00011,191,000,0009,854,000,00018,243,000,00023,435,000,00017,110,000,00017,026,000,000
CFO
15.61b
P
3,542,000,0007,801,000,0005,882,000,0008,621,000,0004,123,000,00010,679,000,0005,892,000,0007,559,000,00013,189,000,0009,383,000,00012,505,000,00010,765,000,00011,356,000,00010,843,000,0009,819,000,0009,217,000,00013,945,000,00025,699,000,000-2,513,000,00015,607,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Jan 31, 2025

Profile

Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
URL
https://www.nihonkohden.co.jp/
IPO date
Nov 02, 1961
Employees
5,751
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
221,986,000
7.45%
206,603,000
0.72%
205,129,000
2.70%
Cost of revenue
199,615,000
182,821,000
110,839,000
Unusual Expense (Income)
NOPBT
22,371,000
23,782,000
94,290,000
NOPBT Margin
10.08%
11.51%
45.97%
Operating Taxes
12,342,000
7,606,000
10,827,000
Tax Rate
55.17%
31.98%
11.48%
NOPAT
10,029,000
16,176,000
83,463,000
Net income
17,026,000
-0.49%
17,110,000
-26.99%
23,435,000
28.46%
Dividends
(5,968,000)
(5,733,000)
(4,842,000)
Dividend yield
0.89%
0.95%
0.98%
Proceeds from repurchase of equity
(1,124,000)
(1,001,000)
(2,344,000)
BB yield
0.17%
0.17%
0.47%
Debt
Debt current
615,000
424,000
335,000
Long-term debt
114,000
55,000
58,000
Deferred revenue
669,000
1,073,000
Other long-term liabilities
1,948,000
1,597,000
1,650,000
Net debt
(43,240,000)
(52,979,000)
(68,934,000)
Cash flow
Cash from operating activities
15,607,000
(2,513,000)
25,699,000
CAPEX
(4,786,000)
(8,256,000)
(2,934,000)
Cash from investing activities
(5,208,000)
(7,647,000)
(4,303,000)
Cash from financing activities
(6,968,000)
(7,485,000)
(7,300,000)
FCF
739,000
(9,766,000)
84,540,000
Balance
Cash
50,432,000
44,459,000
60,925,000
Long term investments
(6,463,000)
8,999,000
8,402,000
Excess cash
32,869,700
43,127,850
59,070,550
Stockholders' equity
171,122,000
327,671,000
306,146,000
Invested Capital
150,812,300
124,003,150
94,720,450
ROIC
7.30%
14.79%
89.57%
ROCE
12.16%
14.21%
61.20%
EV
Common stock shares outstanding
168,204
168,036
168,036
Price
4,004.00
11.53%
3,590.00
21.65%
2,951.00
-8.64%
Market cap
673,488,816
11.64%
603,249,929
21.65%
495,874,803
-8.64%
EV
630,248,816
710,869,929
577,832,803
EBITDA
26,224,000
27,573,000
97,780,000
EV/EBITDA
24.03
25.78
5.91
Interest
24,000
10,000
11,000
Interest/NOPBT
0.11%
0.04%
0.01%